Who owns HCW BIOLOGICS INC?
- Ticker: HCWB
- CUSIP Number: 40423r303
Tip: Access positions for across all investors
Analyze quarterly positions in Hcw Biologics with up to 7 years of data, all consolidated into one spreadsheet
Download as csvTop investors of Hcw Biologics stock
Who bought or sold HCW BIOLOGICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Jane Street | 52k | $260k | 100% | Jun 2026 |
|
| Citadel Advisors | 20k | $100k | 100% | Jun 2026 |
|
| Hrt Financial | 14k | $67k | 100% | Jun 2026 |
|
| Geode Capital Management | 12k | $20k | 100% | Sep 2026 |
|
| Vanguard Fiduciary Trust | 6.5k | $33k | 100% | Jun 2026 |
|
| Tower Research Capital | 4.1k | $21k | 100% | Jun 2026 |
|
| Connective Capital Management | 3.3k | $17k | 100% | Jun 2026 |
|
| Vanguard Capital Management | 2.0k | $10k | 100% | Jun 2026 |
|
| Golden State Wealth Management | 1.7k | $2.9k | 0% | Sep 2026 |
|
| Citigroup | 514.00 | $878.991400 | 100% | Sep 2026 |
|
| Advisor Group Holdings | 4.00 | $20.000000 | 100% | Jun 2026 |
|
| Caitong International Asset Management | 4.00 | $7.000000 | -64% | Sep 2026 |
|
| UBS Group | 1.00 | $5.000000 | 100% | Jun 2026 |
|
Who sold out of Hcw Biologics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Barclays | Jun 2026 | 191.00 | $952.994500 |